HomeCompareTNTFF vs MRK

TNTFF vs MRK: Dividend Comparison 2026

TNTFF yields 3.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.6K in total portfolio value
10 years
TNTFF
TNTFF
● Live price
3.57%
Share price
$1.40
Annual div
$0.05
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.2K
Annual income
$449.34
Full TNTFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TNTFF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTNTFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TNTFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TNTFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TNTFF
Annual income on $10K today (after 15% tax)
$303.57/yr
After 10yr DRIP, annual income (after tax)
$381.94/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,946.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TNTFF + MRK for your $10,000?

TNTFF: 50%MRK: 50%
100% MRK50/50100% TNTFF
Portfolio after 10yr
$41.0K
Annual income
$5,123.74/yr
Blended yield
12.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TNTFF
No analyst data
Altman Z
1.7
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TNTFF buys
0
MRK buys
0
No recent congressional trades found for TNTFF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTNTFFMRK
Forward yield3.57%2.76%
Annual dividend / share$0.05$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$25.2K$56.8K
Annual income after 10y$449.34$9,798.13
Total dividends collected$4.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TNTFF vs MRK ($10,000, DRIP)

YearTNTFF PortfolioTNTFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,057$357.14$11,206$366.19$149.00MRK
2$12,200$369.06$12,650$502.35$450.00MRK
3$13,435$380.58$14,407$694.19$972.00MRK
4$14,767$391.67$16,585$967.82$1.8KMRK
5$16,203$402.34$19,342$1,363.89$3.1KMRK
6$17,750$412.59$22,913$1,947.19$5.2KMRK
7$19,415$422.41$27,662$2,823.89$8.2KMRK
8$21,205$431.80$34,159$4,173.35$13.0KMRK
9$23,131$440.78$43,337$6,308.80$20.2KMRK
10$25,199$449.34$56,776$9,798.13$31.6KMRK

TNTFF vs MRK: Complete Analysis 2026

TNTFFStock

PostNL N.V. provides postal and logistics services to businesses and consumers in the Netherlands, rest of Europe, and internationally. The company operates in two segments, Parcels, Mail in the Netherlands; and PostNL Other. It collects, sorts, transports, and delivers letters and parcels; and offers data and document management, direct marketing, and fulfillment services, as well as cross-border mail solutions. The company was formerly known as TNT N.V. and changed its name to PostNL N.V. in May 2011. PostNL N.V. is headquartered in the Hague, the Netherlands.

Full TNTFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TNTFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TNTFF vs SCHDTNTFF vs JEPITNTFF vs OTNTFF vs KOTNTFF vs MAINTNTFF vs JNJTNTFF vs ABBVTNTFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.